Assessing faculty financial relationships with industry - A case study

被引:119
作者
Boyd, EA
Bero, LA
机构
[1] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA
[2] Dept Vet Affairs, Ctr Hlth Care Evaluat, Hlth Serv Res & Dev Program, Palo Alto, CA USA
[3] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Chancellors Advisory Panel Relat Ind, San Francisco, CA 94143 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 284卷 / 17期
关键词
D O I
10.1001/jama.284.17.2209
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Context A growing number of academic researchers receive industry funding for clinical and basic research, but little is known about the personal financial relationships of researchers with their industry sponsors. Objectives To assess the extent to which faculty researchers have personal financial relationships with the sponsors of their research, the nature of those financial relationships, and efforts made at the institutional level to address disclosed financial relationships and perceived conflicts of interest. Design and Setting Case study of the University of California, San Francisco (UCSF). Data sources included disclosure forms and official documents maintained by the UCSF Office of Research Administration from December 1980 to October 1999, including decisions made by the UCSF Chancellor's Advisory Panel on Relations with Industry. Main Outcome Measures Number and types of personal financial relationships with external sponsors (positive financial disclosures from all clinical, basic, or social science faculty who were principal investigators), amount of annual income received from sponsors, and decisions and management strategies used by the advisory panel. Results By 1999, almost 7.6% of faculty investigators reported personal financial ties with sponsors of their research. Throughout the study period, 34% of disclosed relationships involved paid speaking engagements (range, $250-$20000 per year), 33% involved consulting agreements between researcher and sponsor (range, <$1000-$120 000 per year), and 32% involved the investigator holding a position on a scientific advisory board or board of directors. Fourteen percent involved equity ownership, and 12% involved multiple relationships. The advisory panel recommended managing perceived conflicts of interest in 26% of the cases, including recommending the sale of stock, ref using additional payment for talks, resigning from a management position, or naming a new principal investigator for a project. Conclusions Faculty researchers are increasingly involved in financial relationships with their research sponsors. Guidelines for what constitutes a conflict and how the conflict should be managed are needed if researchers are to have consistent standards of behavior among institutions.
引用
收藏
页码:2209 / 2214
页数:6
相关论文
共 18 条
[1]
Is academic medicine for sale? [J].
Angell, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1516-1518
[2]
Disclosure of authors' conflicts of interest: A follow-up. [J].
Angell, M ;
Utiger, RD ;
Wood, AJJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :586-587
[3]
Relationships between academic institutions and industry in the life sciences - An industry survey [J].
Blumenthal, D ;
Causino, N ;
Campbell, E ;
Louis, KS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :368-373
[4]
Participation of life-science faculty in research relationships with industry [J].
Blumenthal, D ;
Campbell, EG ;
Causino, N ;
Louis, KS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (23) :1734-1739
[6]
Withholding research results in academic life science - Evidence from a national survey of faculty [J].
Blumenthal, D ;
Campbell, EG ;
Anderson, MS ;
Causino, N ;
Louis, KS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (15) :1224-1228
[7]
Uneasy alliance - Clinical investigators and the pharmaceutical industry [J].
Bodenheimer, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1539-1544
[8]
Looking a gift horse in the mouth - Corporate gifts supporting life sciences research [J].
Campbell, EG ;
Louis, KS ;
Blumenthal, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (13) :995-999
[9]
CARLSON S, 2000, CHRON HIGHER ED 0414, pA49
[10]
The quality of drug studies published in symposium proceedings [J].
Cho, MK ;
Bero, LA .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (05) :485-+